Haptoglobin polymorphism as a risk factor for chronic kidney disease: A case-control study

American Journal of Nephrology

Volumn 33, Issue 6, 2011, Pages 510-514

  Chen, Yi Chun ^a,d   Lee, Ching Chih ^b,d   Huang, Chih Yuan ^a   Huang, Hsien Bin ^c   Yu, Chi Chia ^b   Ho, Yu Chen ^b   Su, Yu Chieh ^b,d  

^a Division of Nephrology   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Chronic kidney disease; Haptoglobin polymorphism

Indexed keywords

HAPTOGLOBIN;

AGED; ARTICLE; CASE CONTROL STUDY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; DYSLIPIDEMIA; ELECTROPHORESIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPTOGLOBINS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RENAL INSUFFICIENCY, CHRONIC; TAIWAN;

EID: 79955559110     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000327822     Document Type: Article

References (26)

1. Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, Tsai SP, Chiang PH, Hsu CC, Sung PK, Hsu YH, Wen SF: All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462293 adults in Taiwan. Lancet 2008;371:2173-2182. (Pubitemid 351890412)
2. Kronenberg F: Emerging risk factors and markers of chronic kidney disease progression. Nat Rev Nephrol 2009;5:677-689.
3. Levy AP, Asleh R, Blum S, Levy NS, Miller-Lotan R, Kalet-Litman S, Anbinder Y, Lache O, Nakhoul FM, Asaf R, Farbstein D, Pollak M, Soloveichik YZ, Strauss M, Alshiek J, Livshits A, Schwartz A, Awad H, Jad K, Goldenstein H: Haptoglobin: basic and clinical aspects. Antioxid Redox Signal 2010; 12:293-304.
4. Sadrzadeh SM, Bozorgmehr J: Haptoglobin phenotypes in health and disorders. Am J Clin Pathol 2004;121(suppl):S97-S104.
5. Langlois MR, Delanghe JR: Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996;42: 1589-1600. (Pubitemid 26354735)
6. Levy AP, Roguin A, Hochberg I, Herer P, Marsh S, Nakhoul FM, Skorecki K: Haptoglobin phenotype and vascular complications in patients with diabetes. N Engl J Med 2000;343:969-970.
7. Nakhoul FM, Zoabi R, Kanter Y, Zoabi M, Skorecki K, Hochberg I, Leibu R, Miller B, Levy AP: Haptoglobin phenotype and diabetic nephropathy. Diabetologia 2001;44: 602-604. (Pubitemid 32411276)
8. Lee CC, Lin HY, Hung SK, Li DK, Ho HC, Lee MS, Tung YT, Chou P, Su YC: Haptoglobin genotypes in nasopharyngeal carcinoma. Int J Biol Markers 2009;24:32-37.
9. Conway BR, Savage DA, Brady HR, Maxwell AP: Association between haptoglobin gene variants and diabetic nephropathy: haptoglobin polymorphism in nephropathy susceptibility. Nephron 2007;105:e75-e79. (Pubitemid 46438566)
10. Bessa SS, Hamdy SM, Ali EM: Haptoglobin gene polymorphism in type 2 diabetic patients with and without nephropathy: an Egyptian study. Eur J Intern Med 2007; 18: 489-495. (Pubitemid 47379544)
11. Koda Y, Soejima M, Yamagishi S, Amano S, Okamoto T, Inagaki Y, Yamada K, Kimura H: Haptoglobin genotype and diabetic microangiopathies in Japanese diabetic patients. Diabetologia 2002;45:1039-1040. (Pubitemid 34762201)
12. Moczulski DK, Rogus JJ, Krolewski AS: Comment to: F.M. Nakhoul et al. (2001) Haptoglobin phenotype and diabetes. Diabetologia 44:602-604.
13. Diabetologia 2001;44: 2237-2238.
14. Wobeto VP, Garcia PM, Zaccariotto TR, Sonati Mde F: Haptoglobin polymorphism and diabetic nephropathy in Brazilian diabetic patients. Ann Hum Biol 2009;36:437-441.
15. Kuo HW, Tsai SS, Tiao MM, Yang CY: Epidemiological features of CKD in Taiwan. Am J Kidney Dis 2007;49:46-55.
16. Guh JY, Chen HC, Tsai JF, Chuang LY: Herbal therapy is associated with the risk of CKD in adults not using analgesics in Taiwan. Am J Kidney Dis 2007;49:626-633.
17. Parker WC, Beam AG: Haptoglobin and transferrin variation in humans and primates: two new transferrins in Chinese and Japanese populations. Ann Hum Genet 1961; 25:227-241.
18. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470. (Pubitemid 29135798)
19. Tsai JC, Chen SC, Hwang SJ, Chang JM, Lin MY, Chen HC: Prevalence and risk factors for CKD in spouses and relatives of hemodialysis patients. Am J Kidney Dis 2010; 55: 856-866.
20. Shih LY, Hsia DY: The distribution of genetic polymorphisms among Chinese in Taiwan. Hum Hered 1969;19:227-233.
21. Dounousi E, Papavasiliou E, Makedou A, Ioannou K, Katopodis KP, Tselepis A, Siamopoulos KC, Tsakiris D: Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis 2006;48: 752-760. (Pubitemid 44740054)
22. Kato GJ: Haptoglobin halts hemoglobin's havoc. J Clin Invest 2009;119:2140-2142.
23. Lim YK, Jenner A, Ali AB, Wang Y, Hsu SI, Chong SM, Baumman H, Halliwell B, Lim SK: Haptoglobin reduces renal oxidative DNA and tissue damage during phenyl-hydrazine-induced hemolysis. Kidney Int 2000;58:1033-1044.
24. Nakhoul FM, Miller-Lotan R, Awad H, Asleh R, Jad K, Nakhoul N, Asaf R, Abu-Saleh N, Levy AP: Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus. Am J Physiol Renal Physiol 2009;296:F830-F838.
25. Levy AP, Levy JE, Kalet-Litman S, Miller-Lotan R, Levy NS, Asaf R, Guetta J, Yang C, Purushothaman KR, Fuster V, Moreno PR: Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque. Arterioscler Thromb Vase Biol 2007;27:134-140. (Pubitemid 46360390)
26. Manitius J: Inflammation, malnutrition and vascular contraction in experimental chronic kidney disease. J Nephrol 2007;20:423-429. (Pubitemid 350081496)